Skip to main content
OpenTrials
Completed

NCT Number: NCT04744415

Hospitalizations During Pandemia in the Italian Coronary Care Unit Network

Multicentre, national, observational, retrospective and prospective study.

The BLITZ-COVID19 study aims at describing the epidemiology of admissions to Italian Cardiology Intensive Care Units in the COVID-19 infection pandemia, the main aspects of the clinical management of inpatients, their short-term outcome, the absorption of resources related to their admission.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Management and Epidemiology of Patients Admitted in ICU

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ospedale Santo Spirito - Sc Cardiologia, Casale Monferrato, AL, Italy

Loading trial locations.

About this study

The BLITZ-COVID19 study, aims at describing the epidemiology of admissions to Italian Cardiology Intensive Care Units .

The study is observational, multicentre, national and involves the collection of clinical data, both retrospectively and prospectively, using a web-based system. In conducting the study, no drugs are tested, nor are diagnostic tests or non-pharmacological therapies performed other than those that each participating cardiologist decides to perform following the rules of normal clinical practice. Diagnostic procedures and pharmacological and non-pharmacological therapies habitually prescribed for cardiovascular pathologies, which are the object of hospitalization, and those used in the event of a COVID-19 infection, will be recorded in the database.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients aged ≥18 years admitted with any diagnosis to one of the participating ICU

Exclusion criteria

  • Refuse to signe consent

Treatment and study plan

Epidemiology of admissions

Other

Cardiology Intensive Care Unit admission

Primary outcomes

  1. Impact that COVID-19 infection may have had on the in-hospital mortality

    Time frame: Enrollment

    Impact that COVID-19 infection may have had on the in-hospital mortality of the various clinical conditions admitted to ICU

  2. Epidemiology and management of patients admitted to ICU

    Time frame: Enrollment

    The different diagnoses of discharge from the ICU and their frequency will be described. All hospitalized cardiac and non-cardiac pathologies will be listed, with particular reference to any COVID-19 infection.

  3. Management of patients admitted to ICU

    Time frame: Enrollment

    Description of the main therapeutic decision in patients hospitalized for the most relevant pathologies

Sponsors and collaborators

Lead sponsor

Heart Care Foundation

Other

Registry information

Official study title

Epidemiology of the Hospitalizations in the Italian Coronary Care Unit Network at the Time of Covid19

Acronym: BLITZ-COVID19

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Feb 9, 2021
Registry last updated
Jan 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.